ACTO Recognized as “Life Sciences Commercial Analytics and AI Trailblazer” by Everest Group

Toronto, October 26, 2022: ACTO, the #1 learning platform in Life Sciences, has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence (AI) by Everest Group, a leading global research firm focused exclusively on strategic IT, business process, and engineering services. In its  “Start-ups Creating Buzz in the Life Sciences Commercial Technology” 2022 market report,  Everest Group …

ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences

TORONTO, July 7, 2022 – ACTO, the omnichannel learning and enablement platform for life sciences, today announced the closing of a US$18 million equity financing. The investment was led by Questa Capital, a healthcare venture growth equity firm that actively invests in healthcare and life sciences software. With this investment, Questa joins ACTO’s existing investors: Resolve Growth Partners, Salesforce Ventures, Panache Ventures, and …

ACTO launches LAICA, the first AI-powered conversational assistant for Life Sciences learning

TORONTO, June 15, 2022: ACTO, the only complete commercial learning platform for the Life Science industry, announced the launch of “LAICA™“, an artificial intelligence (AI)-powered conversational assistant, like a SIRI™, for Life Sciences learning. LAICA is the only voice search assistant on the market that supports learning for Life Sciences commercial and medical affairs teams in real-time. LAICA helps pharmaceutical …

Episode 8: Omnichannel Education – The Future of Life Sciences

In this episode, Parth Khanna, CEO of ACTO, speaks with Scot Noel, Owner of NOELEDGE Consulting, on why adopting an omnichannel education strategy is more important than ever today for the life sciences industry.  Scot Noel Founder and CEO of NOELEDGE Consulting

ACTO Integrates Life Sciences Education Platform with Veeva CRM

Education leader supports field teams’ hybrid outreach strategies; earns Silver Certified Veeva Technology Partner status TORONTO, Dec. 2, 2021 /PRNewswire/ – ACTO, the omnichannel education platform for life sciences, today announced it advanced its partnership level with Veeva Systems, the global leader in cloud software for the life sciences industry. ACTO’s newly certified integration for ACTO 2.5 leverages Veeva CRM data, such as sales reps’ territories …

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

TORONTO, Sept. 10, 2020 /PRNewswire/ – ACTO, the leading omnichannel education and engagement platform for life sciences, today announced its acquisition of Scrimmage, a pioneering mobile learning provider. Following ACTO’s $11.5M Series A round, the acquisition establishes ACTO as a life sciences SaaS leader with an unparalleled portfolio of 100+ clients, including seven of the top 20 pharma companies and six of the top …

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

TORONTO, Aug. 27, 2020 /PRNewswire/ – ACTO, the omnichannel education and engagement platform for life sciences, today announced the closing of a $11.5 million Series A round led by Resolve Growth Partners, a Baltimore-based growth equity firm focused on software entrepreneurs. The round also includes strategic funding from new investor Salesforce Ventures, as well as follow-on investment from existing investor Panache Ventures. ACTO is a …

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …

ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

TORONTO, Jan. 31, 2019 /CNW/ – ACTO Technologies Inc. emerged as a leader in life sciences commercialization by closing a strong calendar year 2018 with 184% revenue growth and a doubled customer base. This past year, ACTO secured global, innovative pharmaceutical, medical device, and dental companies like Kala Pharmaceuticals, Teleflex, and Kulzer Dental US as clients. “At ACTO, we are on a …